Integration of Medical Devices related incidents with MvPI
QAI is organising a webinar in collaboration with Indian Pharmacopoeia Commission , a “Brainstorming Session on the integration of Medical Devices related incidents with MvPI”.
Program Details :
Date – Dec 22nd 2021, Wednesday
Time – 03:00 PM – 04:00 PM
Registration :
Register in advance for this meeting here :
https://us02web.zoom.us/meeting/register/tZUtf-qsrjsjHtcC1HfIZx4jGnvYwSTuYktw
About QAI – Quality & Accreditation Institute
QAI was set up to create an ecosystem of education, training, quality improvement and accreditation/ certification. It provides a platform to stakeholders including professionals and organisations, associated with quality in any way, to share their wisdom and knowledge in order to make its Vision realised. QAI aims to operate globally. One of the vertical set up within QAI is the Centre for Accreditation of Health and Social Care (CAHSC). It is responsible to run various accreditation/ certification activities in health and social care.
About Indian Pharmacopoeia Mission
Indian Pharmacopoeia Commission (IPC) is an Autonomous Institution of the Ministry of Health and Family Welfare, Govt. of India. IPC is created to set standards of drugs in the country. Its basic function is to update regularly the standards of drugs commonly required for treatment of diseases prevailing in this region. It publishes official documents for improving Quality of Medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP). It further promotes rational use of generic medicines by publishing National Formulary of India. IP prescribes standards for identity, purity and strength of drugs essentially required from health care perspective of human beings and animals. IPC also provides IP Reference Substances (IPRS) which act as a finger print for identification of an article under test and its purity as prescribed in IP.
About Materio Vigilance Program of India
Materiovigilance Programme of India was launched by DCG (I) on 6th July 2015 at Indian Pharmacopoeia Commission (IPC) Ghaziabad. Indian Pharmacopoeia Commission functions as a National Coordination Centre (NCC) for MvPI.
After several horrific cases of malfunctioning medical devices, like babies being burnt to death due to short circuits in incubators or hip implants causing blood poisoning, the Ministry of Health & Family Welfare (MoHFW), Govt. of India (GoI) has approved Materiovigilance Programme of India (MvPI) in an effort to ensure safety of medical devices. In addition to
protection of health and safety of patients, Materiovigilance program reduces the likelihood of reoccurrence of the harmful incidents elsewhere thereby improving quality of health products.
Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST),
Thiruvananthapuram, shall act as National Collaboration Centre, National Health System Resource Centre (NHSRC), New Delhi shall act as Technical Support & Resource Centre and Central Drugs Standard Control Organisation (CDSCO), New Delhi shall act as Regulator.
For more information and updates, visit –
http://www.ipc.gov.in/mandates/pvpi/materiovigilance-programme-of-india-mvpi.html